Recombinant Human OGDH Protein，His

The study of OGDH (Oxoglutarate Dehydrogenase) recombinant protein has gained significant interest in the field of biochemistry and metabolic research due to its central role in cellular metabolism. OGDH is a key enzyme in the tricarboxylic acid (TCA) cycle, where it catalyzes the oxidative decarboxylation of alpha-ketoglutarate to succinyl-CoA, generating NADH in the process. This reaction not only contributes to ATP production but also ties into various metabolic pathways, influencing the synthesis of amino acids and neurotransmitters. Dysregulation of OGDH has been implicated in several diseases, including neurodegenerative conditions and cancer, making it a crucial target for therapeutic interventions. The recombinant production of OGDH facilitates in-depth studies on its structural and functional characteristics, enabling researchers to explore its mechanisms of action and regulation. Additionally, these studies provide insights into the enzyme's role in metabolic disorders and may lead to the development of novel strategies for disease treatment. Advances in protein engineering and expression systems have streamlined the generation of high-purity recombinant OGDH, allowing for comprehensive biochemical and biophysical analyses. Understanding the dynamics of OGDH at a molecular level is essential for uncovering its biological significance and potential as a biomarker or therapeutic target. Thus, the research on OGDH recombinant protein not only contributes to the fundamental understanding of metabolic processes but also holds promising implications for medical science and biotechnology.